摘要
目的探讨多种肿瘤标志物的联合检测对宫颈癌的诊断及预后判断中的临床价值。方法将以已经确诊的100例宫颈癌患者作为实验组,以同期体检的100例健康妇女作为对照组,分别采用化学发光法检测两组患者中鳞状细胞癌抗原SCC,CA19-9,CA125以及CEA的水平。结果各个肿瘤标志物的水平实验组明显高于对照组,而且其还与宫颈癌临床分期和病理分化程度相关(P<0.05)。结论 SCC、CA19-9、CA125以及CEA等肿瘤标志物的联合检测,对宫颈癌的诊断以及预后判断,具有一定辅助价值。
Objective To investigate the clinical value of combined detection of multiple tumor markers on the diagnosis and prognosis of cervical cancer .Methods 100 patients with cervical cancer was the experimental group ,and 100 healthy women was the control group ,SCC antigen,CA19-9,CA125 and CEA levels of the 2 groups were detected by chemiluminescent method . Results Multiple tumor markers levels in the experimental group were higher than that of the control group ,and they were relat-ed with clinical stage and pathological degree of differentiation in cervical cancer (P<0.05).Conclusion Combined detection of SCC,CA19-9,CA125,CEA and other tumor markers can help in the diagnosis and prognosis of cervical cancer ,and has clinical value.
出处
《实用癌症杂志》
2014年第9期1089-1090,1104,共3页
The Practical Journal of Cancer
关键词
肿瘤标志物
宫颈癌
诊断
预后判断
Tumor markers
Cervical cancer
Diagnosis
Prognosis
